Management of coagulopathy in liver disease.
作者信息
Caldwell Stephen H
机构信息
Professor of Medicine Department of Medicine Division of Gastroenterology and Hepatology University of Virginia School of Medicine Charlottesville, Virginia.
出版信息
Gastroenterol Hepatol (N Y). 2014 May;10(5):330-2.
Abstract
摘要
相似文献
1
Management of coagulopathy in liver disease.
Gastroenterol Hepatol (N Y). 2014 May;10(5):330-2.
2
Coagulopathy of Liver Disease.
Curr Treat Options Gastroenterol. 2000 Dec;3(6):433-438. doi: 10.1007/s11938-000-0030-y.
3
Flow, Liver, Flow: A Retrospective Analysis of the Interplay of Liver Disease and Coagulopathy in Chronic Subdural Hematoma.
World Neurosurg. 2017 Jun;102:246-252. doi: 10.1016/j.wneu.2017.03.014. Epub 2017 Mar 11.
4
Management of coagulopathy in patients with decompensated liver cirrhosis.
Int J Hepatol. 2011;2011:695470. doi: 10.4061/2011/695470. Epub 2011 Nov 17.
5
Analysis of risk factors affecting coagulopathy after donor hepatectomy in a newly established liver transplant center.
Turk J Surg. 2017 Jun 1;33(2):69-75. doi: 10.5152/turkjsurg.2017.3352. eCollection 2017.
6
Risk factors for coagulopathy after liver resection.
J Clin Anesth. 2014 Dec;26(8):654-62. doi: 10.1016/j.jclinane.2014.08.002. Epub 2014 Nov 17.
7
Coagulopathy of acute liver failure.
Clin Liver Dis. 2009 Feb;13(1):95-107. doi: 10.1016/j.cld.2008.10.001.
8
Coagulopathy in a subtype of choledochal cyst and management strategy.
World J Gastroenterol. 2014 Aug 14;20(30):10606-12. doi: 10.3748/wjg.v20.i30.10606.
9
Percutaneous tracheostomy in patients with severe liver disease and a high incidence of refractory coagulopathy: a prospective trial.
Crit Care. 2007;11(5):R110. doi: 10.1186/cc6143.
10
Diagnosis and treatment of coagulopathy following percutaneous cryoablation of liver tumors: experience in 372 patients.
Cryobiology. 2013 Oct;67(2):146-50. doi: 10.1016/j.cryobiol.2013.06.004. Epub 2013 Jul 4.
引用本文的文献
1
Effect of FFP Transfusion on International Normalized Ratio in Liver Disease Patients.
Indian J Hematol Blood Transfus. 2018 Oct;34(4):719-722. doi: 10.1007/s12288-018-0934-0. Epub 2018 Mar 3.
本文引用的文献
1
Coagulation in liver disease: a guide for the clinician.
Clin Gastroenterol Hepatol. 2013 Sep;11(9):1064-74. doi: 10.1016/j.cgh.2013.02.026. Epub 2013 Mar 16.
2
Clotting activation and hyperfibrinolysis in cirrhosis: implication for bleeding and thrombosis.
Semin Thromb Hemost. 2013 Jun;39(4):426-33. doi: 10.1055/s-0033-1334144. Epub 2013 Mar 13.
3
The coagulopathy of chronic liver disease.
N Engl J Med. 2011 Jul 14;365(2):147-56. doi: 10.1056/NEJMra1011170.
4
Hemostasis and thrombosis in patients with liver disease: the ups and downs.
J Hepatol. 2010 Aug;53(2):362-71. doi: 10.1016/j.jhep.2010.01.042. Epub 2010 May 12.
5
Intranasal desmopressin versus blood transfusion in cirrhotic patients with coagulopathy undergoing dental extraction: a randomized controlled trial.
J Oral Maxillofac Surg. 2010 Jan;68(1):138-43. doi: 10.1016/j.joms.2009.07.081.
6
The role of anti-fibrinolytics, rFVIIa and other pro-coagulants: prophylactic versus rescue?
Clin Liver Dis. 2009 Feb;13(1):87-93. doi: 10.1016/j.cld.2008.09.005.
Zotero 插件